MINT-LETROZOLE
MINT-LETROZOLE
Approved
DIN Number
02508109
Drug Class
Human
Market Date
Jul 20, 2021
Company
HC
mint pharmaceuticals inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02508109
AIG Number0132937001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L02BG04 LETROZOLE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
LETROZOLEActive
Strength: 2.5 MG
Monograph: LETROZOLE